Correction to: Nature Communications https://doi.org/10.1038/s41467-024-49092-5, published online 13 June 2024
The abstract for this article was inadvertently truncated after the text ‘…A larger clinical trial to confirm these findings is needed.’; the following text was missing ‘Clinical Trials.gov registration: NCT03743636’. The original article has been updated.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
McDermott, M.M., Martens, C.R., Domanchuk, K.J. et al. Publisher Correction: Nicotinamide riboside for peripheral artery disease: the NICE randomized clinical trial. Nat Commun 15, 6890 (2024). https://doi.org/10.1038/s41467-024-51289-7
Published:
DOI: https://doi.org/10.1038/s41467-024-51289-7
